Large gap with delayed quotes
|
Last quote
05/29/2026
-
17:31:09
|
Bid
05/29/2026 -
17:40:00
|
Bid Volume |
Ask
05/29/2026 -
17:40:00
|
Ask Volume |
|---|---|---|---|---|
|
78.00
-1.50
(
-1.89% )
|
77.00
|
301 |
81.00
|
1 |
Analysis date: 29.05.2026
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 15.05.2026.
Interest
Weak
Weak
Two stars since 12.05.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 12.05.2026 at a price of 75.50.
Evaluation
Undervalued
Undervalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
Negative
Negative
The dividend-adjusted forty day technical trend is negative since 24.04.2026.
4wk Rel Perf
-13.44%
-13.44%
The four-week dividend-adjusted underperformance versus STOXX600 is 13.44%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 15.05.2026.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.62%.
Mkt Cap in $bn
1.68
1.68
With a market capitalization <$2bn, COSMO PHARMACEUTICALS is considered a small-cap stock.
G/PE Ratio
1.22
1.22
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
42.89
42.89
The estimated PE is for the year 2028.
LT Growth
49.73%
49.73%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
5
5
Over the last seven weeks, an average of 5 analysts provided earnings per share estimates.
Dividend Yield
2.53%
2.53%
The earnings forecasts are not sufficient to cover the twelve month estimated dividend.
Beta
148
148
For 1% of index variation, the stock varies on average by 1.48%.
Correlation
0.33
0.33
Stock movements are strongly independent of index variations.
Value at Risk
30.48
30.48
The value at risk is estimated at CHF 30.48. The risk is therefore 39.08%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
10.11.2017
10.11.2017